CluePoints® is a Risk-Based Monitoring and Central Statistical Monitoring solution that has been designed and perfected over the last 15 years. It employs unique statistical algorithms to determine the quality, accuracy, and integrity of clinical trial data both during and after study conduct. Aligned with guidance from the ICH, FDA and EMA, CluePoints® is deployed to support traditional on-site monitoring, medical review and to drive a Risk-Based Monitoring strategy. The value of using CluePoints® lies in its powerful and timely ability to identify anomalous data and site errors allowing improvement in clinical data quality, optimization of on-site monitoring and a significant reduction in overall regulatory submission risk.

Our Vision

CluePoints’ vision is to be THE provider of enabling technologies for Risk-Based Monitoring and Overall Data Quality Oversight within clinical trials. The company strives to improve the quality of clinical research by employing intelligent statistic techniques to interrogate operational and clinical data and support companies in taking corrective action and producing error-free submissions. In future CluePoints will deploy new and groundbreaking techniques such as machine learning to fully exploit the potential of these advanced data analytics in clinical research.

Our Values

Passion: CluePoints’ Founder, Marc Buyse, has been passionate about the detection of fraud in clinical trials over the last two decades and his vision has extended to the wider identification of anomalous data. He evangelises about the use of automated statistical techniques to interrogate large and complex data sets, and his enthusiasm and intellect inspires sponsors, staff and other providers alike.

Innovation: CluePoints strives to deliver software that will help improve clinical data quality and integrity while adhering to both regulatory guidance and the principles of practical implementation.

Accuracy: We are committed to providing the most powerful information to our clients and partners, allowing them to make accurate and timely decisions about their clinical trial conduct.

Integrity: Our company uses its expertise and know-how to improve its solutions and ensure that sponsors get the best out of our software and experience value in everything we do.